🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Efficacy of Additional Motor Training Dosage During the Early Stages Post Stroke on the Upper Extremity Recovery

RecruitingNAAges 18 Years - anyAllAdi Negev-Nahalat Eran
NCT07056049 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Intervention abstract Background: Stroke is the leading cause of long-term disability, and the second leading cause of death in the western world. Most stroke survivors will suffer from motor and cognitive disturbances for the rest of their life, which negatively affects their normal daily life. Despite the decline in stroke-related mortality over the past decades, the outcome of rehabilitation programs does not improve, and is predictable regardless of the program used. Still, several human and animal studies show that high capacity of training in the early stages post stroke improve motor recovery. This notion is far from being well established. Aim: Studying the effect of high-dosage, high-intensity training program in the subacute period on upper extremity motor recovery. Population: Stroke survivors. Study duration: 6 months. Study protocol: Participants will receive additional

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Ischemic or hemorrhagic stroke (hemispheric or brainstem) confirmed by CT or MRI * First-ever stroke or previous stroke with no upper extremity weakness * 1 week ≤ Time after stroke onset ≤ 6 weeks * Active shoulder flexion of at least 20◦ and partial wrist and/or finger active movement * Ability to provide inform consent Exclusion Criteria: * A painful shoulder limiting an active forward reach * Severe spasticity or non-neural loss of range of motion * Cognitive or communication impairments as determined by the clinical team Unstable medical conditions
💊

What it tests

  • High dosage, high intensity motor rehabilitation
📍

Where

2 sites
Adi Negev-Nahalat Eran
Ofakim, Israel
Adi Negev-Nahalat Eran
Ofakim, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy